Efficacy of lumateperone in pooled short-term late-phase clinical trials for the treatment of major depressive episodes associated with bipolar II disorder

被引：0
|
作者：
Durgam, Suresh [1 ]
Lakkis, Hassan [1 ]
Kozauer, Susan G. [1 ]
Chen, Changzheng [1 ]
D'Souza, Ian [1 ]
McIntyre, Roger S. [2 ]
机构：
[1] Intra Cellular Therapies Inc, New York, NY USA
[2] Univ Toronto, Toronto, ON, Canada
来源：
BIPOLAR DISORDERS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P116
引用
下载
收藏
页码：99 / 99
页数：1
相关论文
共 50 条
  • [1] Efficacy of Lumateperone in Pooled Short-Term Late-Phase Clinical Trials for the Treatment of Major Depressive Episodes Associated With Bipolar II Disorder
    Durgam, Suresh
    Lakkis, Hassan
    Kozauer, Susan G.
    Chen, Richard
    D'Souza, Ian
    McIntyre, Roger S.
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 192 - 193
  • [2] Efficacy of Lumateperone in Pooled Short-Term LatePhase Clinical Trials for the Treatment of Major Depressive Episodes Associated With Bipolar II Disorder
    Durgam, Suresh
    Lakkis, Hassan
    Kozauer, Susan G.
    Chen, Richard
    D'Souza, Ian
    McIntyre, Roger S.
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 192 - 193
  • [3] Metabolic Profile of Lumateperone in Late-Phase Clinical Trials for the Treatment of Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
    Mates, Sharon
    Durgam, Suresh
    Kozauer, Susan G.
    Huo, Jason
    Davis, Robert E.
    Correll, Christoph U.
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 195 - 195
  • [4] Metabolic Profile of Lumateperone in Late-Phase Clinical Trials for the Treatment of Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
    Mates, Sharon
    Durgam, Suresh
    Kozauer, Susan G.
    Huo, Jason
    Davis, Robert E.
    Correll, Christoph U.
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 195 - 195
  • [5] Changes in metabolic parameters associated with lumateperone in late-phase clinical trials for treatment of major depressive episodes associated with bipolar I or bipolar II disorder
    Edwards, John
    Durgam, Suresh
    Kozauer, Susan G.
    Huo, Jason
    Davis, Robert E.
    Mates, Sharon
    Correll, Christoph U.
    BIPOLAR DISORDERS, 2023, 25 : 99 - 99
  • [6] Evaluation of Mania and Hypomania in Late-Phase Clinical Trials of Lumateperone in the Treatment of Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
    Tohen, Mauricio
    Kozauer, Susan G.
    Mo, Yifan
    Earley, Willie R.
    Durgam, Suresh
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 198 - 199
  • [7] Evaluation of Mania and Hypomania in Late-Phase Clinical Trials of Lumateperone in the Treatment of Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
    Tohen, Mauricio
    Kozauer, Susan G.
    Mo, Yifan
    Earley, Willie R.
    Durgam, Suresh
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 198 - 199
  • [8] Lumateperone in the Treatment of Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: Evaluation of Extrapyramidal and Motor Symptoms in Late-Phase Clinical Trials
    Escher, Tobie
    Durgam, Suresh
    Kozauer, Susan G.
    Chen, Richard
    Kane, John M.
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 202 - 203
  • [9] Lumateperone in the Treatment of Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: Evaluation of Extrapyramidal and Motor Symptoms in Late-Phase Clinical Trials
    Escher, Tobie
    Durgam, Suresh
    Kozauer, Susan G.
    Chen, Richard
    Kane, John M.
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 202 - 203
  • [10] Lumateperone for treatment of major depressive episodes associated with bipolar I or bipolar II disorder: Evaluation of extrapyramidal and motor symptoms in late-phase clinical trials
    Escher, Tobie
    Durgam, Suresh
    Kozauer, Susan G.
    Chen, Changzheng
    Kane, John M.
    BIPOLAR DISORDERS, 2023, 25 : 95 - 96
12345